Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/SYRE
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Spyre Therapeutics Inc. Common Stock (SYRE) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

SYRE trades at $80.45, down 6.34% over 24 hours, with technical indicators showing neutral momentum near key support at $79. The clinical-stage biotech shows no revenue but maintains strong analyst support (92% buy rating) with a $119.89 consensus target. Recent positive SPY003 phase II ulcerative colitis data (Zacks, 2026-09-09) and a $350 million public offering (GlobeNewsWire, 2026-10-05) provide catalysts, though financials reflect pre-revenue challenges with a -197.71% net margin.
Investment outlook balances high-risk, high-reward potential. The robust pipeline in inflammatory bowel disease offers substantial upside if clinical successes continue, but the absence of revenue, negative cash flow from operations, and reliance on financing pose significant risks. Near-term price action will hinge on Q3 2026 earnings and further clinical updates.
Read full analysis

Key Stats

  • Market Cap
    $7.52B
  • Volume
    1,441,031
  • Sector
    Health
  • 52W High
    $108.92
  • 52W Low
    $22.18
  • Typical Hold Time
    0 Days
  • Enterprise Value
    $6.52B
  • Div Yield
    -
  • Trading Activity
    0% Sell | 100% Buy
$78.63
52W Low: $22.18
10 Nov 2025
52W High: $108.92
19 Aug 2026

Track Spyre Therapeutics Inc. Common Stock (SYRE) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Spyre Therapeutics Inc. Common Stock has traded between a low of $22.18 and a high of $108.92, highlighting its annual price range. Buy and sell Spyre Therapeutics Inc. Common Stock shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Spyre Therapeutics Inc. Common Stock

Spyre Therapeutics develops extended half-life antibody therapies for inflammatory bowel disease, including ulcerative colitis and Crohn's disease. Its pipeline targets pathways such as α4β7, TL1A, and IL-23 with antibodies engineered for infrequent subcutaneous dosing and potential combination use.

Most Recent News

Content is generated by Aura AI

Coro and Activa Digital partner to offer unified AI-driven cybersecurity for lean IT teams.

Coro, a workspace cybersecurity platform designed for organizations with small IT teams, has partnered with Activa Digital, an Italian managed service provider, to deliver Coro's unified cybersecurity platform to Activa's customers. This partnership ...

Market News
1 hour ago
Not Specified
Bullish
news icon
Coro and Activa Digital partner to offer unified AI-driven cybersecurity for lean IT teams.

Coro and Activa Digital partner to offer unified cybersecurity for shared workspaces in Italy.

Coro, a leading cybersecurity platform provider, has partnered with Italian managed service provider Activa Digital to deliver Coro's unified cybersecurity platform to Activa's clients. This collaboration addresses the growing need for simplified, co...

Market News
1 hour ago
Not Specified
Bullish
news icon
Coro and Activa Digital partner to offer unified cybersecurity for shared workspaces in Italy.

Mowi insider's 6,002 shares sold by error during account closure

Mowi ASA reported that Øyvind Oaland, a primary insider, had 6,002 shares sold mistakenly at NOK 204.40 due to an error linked to closing his securities trading account. This sale was unintentional and is disclosed under Norwegian securities regulati...

Market News
1 hour ago
Na
Neutral
Mowi insider's 6,002 shares sold by error during account closure
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $7.52B
  • Volume
    1,441,031
  • Sector
    Health
  • 52W High
    $108.92
  • 52W Low
    $22.18
  • Typical Hold Time
    0 Days
  • Enterprise Value
    $6.52B
  • Div Yield
    -
  • Trading Activity
    0% Sell | 100% Buy
$78.63
52W Low: $22.18
10 Nov 2025
52W High: $108.92
19 Aug 2026

Track Spyre Therapeutics Inc. Common Stock (SYRE) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Spyre Therapeutics Inc. Common Stock has traded between a low of $22.18 and a high of $108.92, highlighting its annual price range. Buy and sell Spyre Therapeutics Inc. Common Stock shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!